Marksans Pharma Limited
MARKSANS.NS
NSE
205.58INR11.43 (6.52%)

About

CEO
Mr. Mark B. Saldanha
Sector
Healthcare
Industry
Drug Manufacturers - General
Website
https://marksanspharma.com
Exchange
NSE
Description
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
CIK
ISININE750C01026
CUSIPY57686100
AddressGrandeur HN
Phone91 22 4001 2000
Country IN
Employee1141
IPO Date2002-07-19

Key Executives

NameTitlePayYear Born
Mr. Jitendra M. SharmaChief Financial Officer01969
Mr. Anjani KumarChief Operating Officer of US Operations01960
Mr. Harshavardhan PanigrahiCompany Secretary, Manager of Legal & Compliance Officer00
Mr. Vishal BhargavaDirector Operations01970
Mr. David MohammedManaging Director of Australia Operations00
Mr. Sathish KumarManaging Director of UK Operations00
Mr. Mark B. SaldanhaNon-Independent Executive Chairman & MD68.86M1972
Mr. Sunil K. RaneSenior Vice President of QC01969
Mr. Varddhman Vikramaditya JainWhole-Time Executive Non Independent Director18.75M1970
Ms. Sandra SaldanhaWhole-Time Executive Non Independent Director7.07M1971